Jeroen de Filette

Dr. Jeroen M.K. de Filette obtained his degree in medicine with the highest distinction at the Vrije Universiteit Brussel in 2016. The following years, he trained as an Internist and Endocrinologist at the Sint-Pieter -, Brugmann - and University Hospital of Brussels. In 2021, he successfully defended his PhD thesis entitled "Endocrine Adverse Events of Immune Checkpoint Therapy”. He has given lectures on this subject at various national and international congresses. Also, in 2020, his abstract on checkpoint blockade therapy in pituitary carcinoma (shared co-first authorship with Bastiaan Sol, MD) received the ‘outstanding abstract award’ from the Endocrine Society. Jeroen de Filette was one of the initiators of the Belgian guidelines on the management of endocrine adverse events associated with immune checkpoint inhibitors, in collaboration with the Belgian Society of Medical Oncology. He has several scientific publications in international peer-reviewed journals and is a member of national and international endocrine organizations. He has reviewed for the New England Journal of Medicine.